Schwab, Ivan R <br/><br/>
A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.  [electronic resource] 

 -  Ophthalmology  Mar 2003 
 - 457-65 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0161-6420 
<br/><br/><label>Standard No.: </label>10.1016/S0161-6420(02)01894-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Infective Agents--administration & dosage<br/>Bacteria--isolation & purification<br/>Child<br/>Child, Preschool<br/>Conjunctiva--microbiology<br/>Conjunctivitis, Bacterial--drug therapy<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Infant<br/>Levofloxacin<br/>Male<br/>Middle Aged<br/>Ofloxacin--administration & dosage<br/>Ophthalmic Solutions<br/>Prospective Studies<br/>Safety<br/>Treatment Outcome